Accuray (ARAY) Capital Expenditures Growth (1y) (2011 - 2026)
Accuray (ARAY) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | 15.89% |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | 106.98% |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | -11.95% |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | -47.73% |
| 10 | Accuray | 29,658.93 | -38.50 Mn | 25.29 Mn | -84.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.04% |
| Dec 31, 2025 | 10,553.66% |
| Sep 30, 2025 | 27.50% |
| Mar 31, 2025 | 1,596.55% |
| Dec 31, 2024 | 104.66% |
| Sep 30, 2024 | -59.71% |
| Mar 31, 2024 | 67.31% |
| Dec 31, 2023 | 7.95% |
| Sep 30, 2023 | -14.15% |
| Mar 31, 2023 | -96.87% |
| Dec 31, 2022 | -219.05% |
| Sep 30, 2022 | -12.64% |
| Mar 31, 2022 | 132.73% |
| Dec 31, 2021 | 34.28% |
| Sep 30, 2021 | 155.89% |
| Mar 31, 2021 | 517.75% |
| Dec 31, 2020 | -52.76% |
| Sep 30, 2020 | -55.09% |
| Jun 30, 2020 | 126.46% |
| Mar 31, 2020 | -77.31% |